Giving semaglutide to people undergoing minimally invasive endoscopic sleeve gastroplasty may bring weight loss closer to that induced by bariatric surgery, shows research.
A meta-analysis shows that bariatric or metabolic surgery markedly increases life expectancy relative to standard obesity care, with the greatest gains seen for people with type 2 diabetes.